Investigational Site Number: 2460001

Turku FI-20520

0 studies enrolling now · 4 studies all time

What they study most

Celiac Disease, Chronic Obstructive Pulmonary Disease, Coeliac Disease, Fabry Disease, RSV Immunisation

Studies at this site

• A Phase 2a/b Study of the Efficacy and Safety of Subcutaneous Amlitelimab in Adults With Nonresponsive Celiac Disease — Running, not enrolling
• A Study to Evaluate the Effect of Venglustat Tablets on Neuropathic and Abdominal Pain in Male and Female Participants ≥16 Years of Age With Fabry Disease — Running, not enrolling
• Efficacy, Immunogenicity, and Safety Study of a Respiratory Syncytial Virus Vaccine in Infants and Toddlers — Stopped early
• Pivotal Study to Assess the Efficacy, Safety and Tolerability of Dupilumab in Patients With Moderate-to-severe COPD With Type 2 Inflammation — Completed